The brown cluster, also representing a niche theme, associates pediatric MASLD with chemerin’s dual inflammatory and anti-inflammatory functions, though it is notably showing elevated levels in NAFL patients, but no significant differences between NASH patients and controls [54]. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatohepatitis.